INS and obesity disorder: Conversely, bromocriptine treatment tended to reduce bodyweight and voluntary activity, and reinforce insulin action in DIO mice.These results show that DRD2 activation partly redirects high fat diet induced metabolic anomalies in obesity-prone mice.